With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower ...

Lex Diagnostics Ltd. has submitted dual applications to the U.S. FDA seeking 510(k) clearance and CLIA waiver status for its ...

Aribio Co. Ltd. signed a $600 million license deal with Acino International AG, an Arcera Life Sciences subsidiary, granting ...

Is fecal microbiota transplant effective? Is it really safe? And is it really all the same? Scientists at the University of ...

Insmed Inc.’s chair and CEO, Will Lewis, called the phase IIb trial of TPIP in pulmonary arterial hypertension a “clear and ...

London-based Livanova plc. has petitioned the U.S. CMS to cover vagus nerve stimulation device for treatment-resistant ...

The trade wars spanning the globe lined up some unlikely-seeming adversaries, and such is the case in the trade scrum between ...

Myosin Therapeutics Inc. has obtained IND clearance by the FDA for MT-125. A phase I study will evaluate MT-125 in ...

Researchers from Guangdong Pharmaceutical University and collaborators reported the discovery of [I], a novel FABP/PPAR ...

Persistent activation of the stimulator of interferon genes (STING), resulting from aberrant metabolism or mutations in ...

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Beone, Compedica, Concentra, Elevation, Formosa, Harrow, Neowise, Nipro, Portage, Samsung ...

Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated ...